Cargando…
Parametric Model of Combination Therapy for Non-Hodgkin Lymphoma
The development and clinical testing of drug combinations for the treatment of Non-Hodgkin Lymphoma (NHL) and other cancers has recently shown great promise. However, determining the optimum combination and its associated dosages for maximum efficacy and minimum side effects is still a challenge. Th...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522695/ https://www.ncbi.nlm.nih.gov/pubmed/23272153 http://dx.doi.org/10.1371/journal.pone.0051736 |